Insider Trading24 Jun 2026, 10:21 am
Sandu Pharmaceuticals Closes Trading Window for Q1 FY27
AI Summary
Sandu Pharmaceuticals Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with SEBI regulations and the company's 'Code of Conduct for Prevention of Insider Trading'. The trading window will be shut from Wednesday, July 1, 2026, until 48 hours after the declaration of the financial results for the quarter ended June 30, 2026. This restriction applies to Directors, KMPs, Promoters, Promoter Group, Designated Persons, and their immediate relatives. The date for the Board Meeting to consider these financial results will be intimated separately.
Key Highlights
- Trading window closed for Q1 FY27 results.
- Effective from July 1, 2026.
- Applies to insiders and designated persons.
- Restriction lasts until 48 hours post-results declaration.
- Board meeting date for results to be announced later.
Price Impact
More from SANDUPHQ